State Street’s Monogram Orthopaedics MGRM Stock Holding History

State Street’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-89,932	Closed	-$528K	–	4325
2025 Q3	$528K	Buy	89,932 +11,932	+15%	+$63.7K	﹤0.01%	3652
2025 Q2	$225K	Hold	78,000	–	–	﹤0.01%	3801
2025 Q1	$229K	Buy	78,000 +46,300	+146%	+$122K	﹤0.01%	3789
2024 Q4	$75.1K	Buy	31,700 +8,400	+36%	+$19.7K	﹤0.01%	4051
2024 Q3	$61.7K	Buy	+23,300	New	+$60.7K	﹤0.01%	4063

State Street's MGRM Position: Q4 2025 in Review

State Street sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 89,932 shares — an estimated $528K sold.

State Street first reported a position in MGRM in Q3 2024 and held it in 5 quarters. The position peaked at $528K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

State Street reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
State Street sold 89,932 Monogram Orthopaedics shares in Q4 2025, an estimated $528K.
State Street first reported a position in Monogram Orthopaedics in Q3 2024 and held it in 5 quarters.
State Street's Monogram Orthopaedics position peaked at $528K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on State Street's 13F filing for Q4 2025, filed 13 Feb 2026.